Scarica l'app Stockscreener
347.07
1.01%
3.47
Pre-mercato:
344.70
-2.37
-0.68%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$343.60
Aprire:
$344.145
Volume 24 ore:
3.02M
Relative Volume:
1.12
Capitalizzazione di mercato:
$186.89B
Reddito:
$35.89B
Utile/perdita netta:
$7.01B
Rapporto P/E:
26.83
EPS:
12.9352
Flusso di cassa netto:
$11.54B
1 W Prestazione:
+5.16%
1M Prestazione:
+4.73%
6M Prestazione:
+13.54%
1 anno Prestazione:
+26.93%
Intervallo 1D:
$342.14
$349.98
Intervallo di 1 settimana:
$321.71
$349.98
Portata 52W:
$261.43
$349.98
Amgen Inc Stock (AMGN) Company Profile
Nome
Amgen Inc
Settore
Industria
Telefono
(805)447-1000
Indirizzo
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Confronta AMGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
347.07 | 185.02B | 35.89B | 7.01B | 11.54B | 12.94 |
|
LLY
Lilly Eli Co
|
1,087.38 | 965.30B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
218.49 | 525.25B | 94.19B | 26.80B | 20.46B | 11.05 |
|
ABBV
Abbvie Inc
|
218.11 | 382.02B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
145.00 | 278.44B | 54.45B | 14.42B | 17.15B | 7.333 |
|
NVO
Novo Nordisk Adr
|
62.23 | 263.59B | 46.69B | 15.29B | 9.25B | 3.4329 |
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Ripresa | UBS | Buy |
| 2025-12-05 | Aggiornamento | Erste Group | Hold → Buy |
| 2025-11-24 | Ripresa | Truist | Hold |
| 2025-11-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-09-03 | Ripresa | Raymond James | Mkt Perform |
| 2025-05-20 | Ripresa | Guggenheim | Neutral |
| 2025-04-22 | Ripresa | Cantor Fitzgerald | Neutral |
| 2024-12-10 | Ripresa | BofA Securities | Underperform |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-14 | Iniziato | Citigroup | Neutral |
| 2024-10-17 | Iniziato | Bernstein | Outperform |
| 2024-10-14 | Downgrade | Truist | Buy → Hold |
| 2024-09-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-08-07 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-05-03 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | Ripresa | Raymond James | Mkt Perform |
| 2024-02-07 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Aggiornamento | Truist | Hold → Buy |
| 2023-10-20 | Ripresa | JP Morgan | Neutral |
| 2023-10-17 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Ripresa | BofA Securities | Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-04-24 | Reiterato | Oppenheimer | Outperform |
| 2023-03-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Reiterato | Truist | Buy |
| 2022-11-18 | Iniziato | Credit Suisse | Underperform |
| 2022-10-31 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Mkt Perform |
| 2022-02-09 | Reiterato | Barclays | Equal Weight |
| 2022-02-09 | Reiterato | Jefferies | Buy |
| 2022-02-09 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Reiterato | Oppenheimer | Outperform |
| 2022-02-09 | Reiterato | Wells Fargo | Equal Weight |
| 2022-01-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-12-06 | Iniziato | Goldman | Buy |
| 2021-11-19 | Iniziato | BMO Capital Markets | Market Perform |
| 2021-09-23 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Iniziato | Daiwa Securities | Buy |
| 2020-10-28 | Iniziato | UBS | Neutral |
| 2020-10-26 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Aggiornamento | Truist | Hold → Buy |
| 2020-10-09 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Downgrade | Truist | Buy → Hold |
| 2020-10-08 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Ripresa | Guggenheim | Neutral |
| 2020-03-31 | Iniziato | Wolfe Research | Peer Perform |
| 2020-03-30 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-31 | Downgrade | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-11-12 | Iniziato | SunTrust | Buy |
| 2019-11-05 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Ripresa | BofA/Merrill | Neutral |
| 2019-08-19 | Downgrade | Mizuho | Buy → Neutral |
| 2019-05-23 | Aggiornamento | Citigroup | Neutral → Buy |
Mostra tutto
Amgen Inc Borsa (AMGN) Ultime notizie
Lockheed Martin Investment Management Co. Makes New $2.62 Million Investment in Amgen Inc. $AMGN - MarketBeat
Analyst recommendations: Amgen, P&G, Spotify, Duolingo, Moderna… - marketscreener.com
Amgen (AMGN) Faces 340B Lawsuit: What Does Sagebrush Dispute Reveal About Its Stakeholder Strategy? - Yahoo Finance
Amgen (AMGN) Outpaces Stock Market Gains: What You Should Know - Nasdaq
Amgen Faces 340B Lawsuit Spotlighting Drug Pricing And Investor Risks - simplywall.st
Amgen (AMGN) expands obesity strategy with Ro collaboration on GLP-1 therapies - MSN
Amgen (NASDAQ:AMGN) Hits New 1-Year HighHere's Why - MarketBeat
Amgen: A Buy In 2026 On Exciting MariTide ObesityT2D Potential (NASDAQ:AMGN) - Seeking Alpha
Amgen stock hits 52-week high at $346.41 - Investing.com
Sagebrush sues Amgen over 340B program row - The Pharma Letter
Rakuten Investment Management Inc. Purchases Shares of 27,258 Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN) Downgraded by Bernstein on Market Challenges - GuruFocus
Ember LifeSciences Taps Former Amgen Exec as CFO - Contract Pharma
Amgen downgraded at Bernstein on 2026 outlook - MSN
Cell and Gene Therapy Market Innovations and Key Players: Amgen - openPR.com
Johnson & Johnson Clears the Patent Cliff as 2026 Guidance Resets the Narrative - Investing.com
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - The AI Journal
Amgen (AMGN) Expands Obesity Strategy With Ro Collaboration on GLP-1 Therapies - Finviz
Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year - simplywall.st
Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.52 - Yahoo Finance
AMGEN INC (NASDAQ:AMGN) Shows High Technical and Setup Ratings for Potential Breakout - Chartmill
Arkadios Wealth Advisors Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen (AMGN): Company Profile, Stock Price, News, Rankings - Fortune
Red Biotechnology Market Is Going to Boom 20262023 |Amgen Inc., Gilead Sciences, Inc., Biogen - openPR.com
Lobbying Update: $3,550,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitative
Sagebrush Health Sues Amgen for Over $7 Million in Damages - Intellectia AI
Amgen (AMGN) Downgraded by Bernstein, Price Target Unchanged | A - GuruFocus
Bernstein downgrades Amgen as 2026 lacks near-term catalysts - Investing.com
Sanford C. Bernstein Downgrades Amgen (NASDAQ:AMGN) to Market Perform - MarketBeat
Seizert Capital Partners LLC Trims Stock Position in Amgen Inc. $AMGN - MarketBeat
Pacific Heights Asset Management LLC Has $23.99 Million Holdings in Amgen Inc. $AMGN - MarketBeat
UPS building massive $6 million cooler - The Business Journals
40 Under 40: Melissa Wagner, Amgen - Medical Marketing and Media
A Look At Amgen (AMGN) Valuation After Strong Q3 Results And Pipeline Momentum - Yahoo Finance
Amgen stock hits pause on MLK Day — what to watch before AMGN returns Tuesday - TechStock²
Tradewinds LLC. Makes New $988,000 Investment in Amgen Inc. $AMGN - MarketBeat
Amgen Inc.'s (NASDAQ:AMGN) Intrinsic Value Is Potentially 93% Above Its Share Price - 富途资讯
Beat the Market the Zacks Way: Amicus, Micron, Amgen in Focus - Yahoo Finance
Royal Fund Management LLC Cuts Holdings in Amgen Inc. $AMGN - MarketBeat
3,785 Shares in Amgen Inc. $AMGN Bought by Campbell & CO Investment Adviser LLC - MarketBeat
Allstate Corp Has $5.54 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
DISCO Oncology Pact And MariTide Obesity Data Might Change The Case For Investing In Amgen (AMGN) - simplywall.st
Sequoia Financial Advisors LLC Has $45.33 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. (NASDAQ:AMGN) is largely controlled by institutional shareholders who own 80% of the company - Yahoo Finance
Amgen’s Obesity Drug May Crush Novo Nordisk & Lilly With Just Four Shots A Year! - Smartkarma
WoodTrust Financial Corp Sells 588,232 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Stock Position Cut by QRG Capital Management Inc. - MarketBeat
Pinnacle Financial Partners Inc Has $13.66 Million Stake in Amgen Inc. $AMGN - MarketBeat
Assessing Amgen (AMGN) Valuation As Shares Track Close To Analyst Targets - simplywall.st
Lobbying Update: $60,000 of AMGEN INC. FKA HORIZON THERAPEUTICS USA INC. lobbying was just disclosed - Quiver Quantitative
Wright Investors Service Inc. Has $2.76 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc Azioni (AMGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.57%
1.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):